Dustin B. Mccurry

Oncology
210 Ashville Ave # 408
Cary, NC 27518

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Molecular and cellular dynamics of measurable residual disease progression in myelodysplastic syndromes.

Molecular and cellular dynamics of measurable residual disease progression in myelodysplastic syndromes.

Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025

ASXL1 truncating mutations drive leukemic resistance to T cell attack.

ASXL1 truncating mutations drive leukemic resistance to T cell attack.

Journal: bioRxiv : the preprint server for biology
Published: July 15, 2025

Immune-based therapies in diffuse large B-cell lymphoma.

Immune-based therapies in diffuse large B-cell lymphoma.

Journal: Expert opinion on investigational drugs
Published: July 03, 2023

Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma.

Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma.

Journal: Nature cancer
Published: June 20, 2023

CAR T-cells and macrophages in large B-cell lymphoma: impact on toxicity and efficacy.

CAR T-cells and macrophages in large B-cell lymphoma: impact on toxicity and efficacy.

Journal: Leukemia & lymphoma
Published: March 09, 2023

Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma.

Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 04, 2020

Severe anaplasmosis represents a treatable cause of secondary hemophagocytic lymphohistiocytosis: Two cases and review of literature.

Severe anaplasmosis represents a treatable cause of secondary hemophagocytic lymphohistiocytosis: Two cases and review of literature.

Journal: Ticks and tick-borne diseases
Published: November 18, 2019

Assessment of inpatient psychiatric readmission risk among patients discharged on an antipsychotic polypharmacy regimen: A retrospective cohort study.

Assessment of inpatient psychiatric readmission risk among patients discharged on an antipsychotic polypharmacy regimen: A retrospective cohort study.

Journal: Acta medica academica
Published: November 21, 2017

Surrogate in vitro activation of innate immunity synergizes with interleukin-7 to unleash rapid antigen-driven outgrowth of CD4+ and CD8+ human peripheral blood T-cells naturally recognizing MUC1, HER2/neu and other tumor-associated antigens.

Surrogate in vitro activation of innate immunity synergizes with interleukin-7 to unleash rapid antigen-driven outgrowth of CD4+ and CD8+ human peripheral blood T-cells naturally recognizing MUC1, HER2/neu and other tumor-associated antigens.

Journal: Oncotarget
Published: October 07, 2016

MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice.

MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice.

Journal: PloS one
Published: September 04, 2015

Myeloid-derived suppressor cells adhere to physiologic STAT3- vs STAT5-dependent hematopoietic programming, establishing diverse tumor-mediated mechanisms of immunologic escape.

Myeloid-derived suppressor cells adhere to physiologic STAT3- vs STAT5-dependent hematopoietic programming, establishing diverse tumor-mediated mechanisms of immunologic escape.

Journal: Immunological investigations
Published: September 29, 2012
Showing 1-11 of 11

Last Updated: 09/26/2026